NPI: 1447223318 · YUMA, AZ 85365 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,318 | $632K |
| 2019 | 42,925 | $678K |
| 2020 | 41,126 | $717K |
| 2021 | 38,966 | $622K |
| 2022 | 34,724 | $496K |
| 2023 | 19,128 | $582K |
| 2024 | 8,615 | $566K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 62,145 | 4,636 | $4.02M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 824 | 516 | $257K |
| A4657 | Syringe, with or without needle, each | 27,503 | 3,996 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | 9,492 | 2,578 | $3K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 54,012 | 3,276 | $1K |
| 83970 | 1,391 | 1,190 | $875.66 | |
| 82728 | 2,021 | 1,745 | $288.98 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,434 | 1,112 | $219.07 |
| 83540 | 2,024 | 1,735 | $137.45 | |
| 85041 | 1,724 | 1,537 | $63.84 | |
| 85048 | 1,720 | 1,533 | $53.92 | |
| 82108 | 633 | 568 | $21.22 | |
| 83550 | 1,711 | 1,449 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 229 | 206 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 31,516 | 2,373 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,567 | 570 | $0.00 |
| 90674 | 115 | 101 | $0.00 | |
| 0064A | 24 | 20 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 19,349 | 1,388 | $0.00 |
| 90661 | 12 | 12 | $0.00 | |
| 90662 | 90 | 82 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 129 | 26 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 137 | 38 | $0.00 |